Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the GORE® VIABIL® Biliary Endoprosthesis in the Treatment of Benign Biliary Strictures Secondary to Chronic Pancreatitis

NCT05820009 is registered in ClinicalTrials.gov with W.L.Gore & Associates as lead sponsor.

NCT NCT05820009
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05820009 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the GORE® VIABIL® Biliary Endoprosthesis in the Treatment of Benign Biliary Strictures Secondary to Chronic Pancreatitis
Lead sponsor
W.L.Gore & Associates
Phase
Not applicable
Overall status
Suspended
Start date
February 1, 2024
Completion date
August 1, 2028
Enrollment
133 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatitis, chronic, stricture; bile duct